Juul Labs CEO Announces Company's Next Steps

Oct.09.2022
Juul Labs CEO Announces Company's Next Steps
Juul CEO announces cancellation of overseas expansion plans, debt refinancing, and potential bankruptcy as the company fights for survival.

Recently, the CEO of Juul Labs Inc., KC Crosthwaite, announced that the company is canceling its plans for international expansion. They have also undergone a refinancing process for some of their debts and are currently struggling to keep the business afloat.


The board of directors, leadership team, and I are continuing to evaluate all options to ensure that we take the necessary steps to help us fight for our mission - a battle that has been going on for many years," said CEO KC Crosthwaite in a statement.


In the ongoing dispute with the U.S. Food and Drug Administration (FDA) over whether its e-cigarettes can remain on the U.S. market, Juul has been preparing to file for bankruptcy protection. Crosthwaite stated that the company is still considering various restructuring plans, including bankruptcy, but has not made any decisions yet.


Crosthwaite announced that the company will be laying off some employees after cancelling its plans to expand outside of the United States. He also stated that Juul has successfully refinanced its debt to allow for more time to explore longer-term options.


We firmly believe that we have a future in which millions of adult smokers around the world will be able to use Juul products," said Crosthwaite. "To make this future a reality, we must continue to fight and make difficult decisions.


In 2018, Juul disrupted the tobacco market when its stylish flash-drive shaped vaporizer drove a surge in electronic cigarette use in the United States. Since then, Juul has faced lawsuits and regulatory crackdowns. The company has attempted to repair its image by appointing a new CEO in 2019 and voluntarily discontinuing the sale of fruit flavors in the US, as well as ceasing most of its marketing activities in the country.


Juul Labs CEO KC Crosthwaite has announced that the company will be laying off employees following a decision to withdraw plans for international expansion. Juul, which had approximately 3,000 employees in 2019, has already cut two-thirds of its workforce due to declining sales and increased losses. The company currently employs around 1,200 workers, including approximately 100 outside of the US, and the impact of the latest layoff decisions on their positions is unclear at this time.


The company Juul had previously planned to expand distribution in Canada, with their latest device JUUL2 launching earlier this year and being sold online and in around three dozen stores in Toronto. Juul also plans to re-establish employees in Italy and Switzerland, where their original e-cigarettes are currently sold through local distributors.


In 2020, due to a voluntary decision to reduce marketing efforts and cease sales of their sweet and fruity flavors in the United States, the company withdrew from most international markets as a result of declining revenue. In June, the FDA ordered Juul to remove their e-cigarettes from the U.S. market, stating insufficient proof of safety. The agency subsequently suspended the order pending Juul's appeal. However, sources reveal that Juul's sales in the U.S. continued to decline, prompting the company to abandon their overseas plans.


Juul faces thousands of lawsuits accusing the company of selling its products to children. Some of these lawsuits are scheduled to go to trial next year. Disputes with the FDA have hindered Juul's ability to raise funds or obtain traditional bank loans to pay for legal settlements or court judgments.


Since last year, Juul has agreed to pay over $525 million in settlements to several states that have been investigating or taking legal action against the company. There are still pending cases, including lawsuits filed by nine other attorneys general. The company maintains that it has never targeted underage users.


According to a federal investigation released on Thursday, Juul did not make it to the list of the most popular e-cigarette brands used by high school students.


Statement:


This article is compiled based on third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The compilation of this article is only intended for industry-related communication and research.


Due to limitations in our translation capabilities, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government in regards to any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
Philip Morris International’s second-quarter net revenues rose 10.4% to a record $11.19 billion, as heated tobacco and e-vapor expanded across international markets. IQOS remained the main smoke-free growth engine, while VEEV shipments jumped 55.1%. In the United States, however, ZYN shipments increased just 1.8% and consumer offtake was broadly flat to slightly higher. Cigarette volumes also rose, showing that PMI’s transformation is advancing, but growth is becoming increasingly uneven across categories and markets.
PMI
Jul.22
BofA Upgrades Imperial Brands, Says Market Overreacted to Australia Slump
BofA Upgrades Imperial Brands, Says Market Overreacted to Australia Slump
Bank of America upgraded Imperial Brands to “buy” from “neutral,” saying investors have overreacted to the tobacco group’s Australian business downturn and that the share-price pullback has created a more attractive entry point.
Jul.16
Product | Vapsolo Launches Sixer 180K, Introducing a 6-in-1 Architecture for Disposable Vapes
Product | Vapsolo Launches Sixer 180K, Introducing a 6-in-1 Architecture for Disposable Vapes
Vapsolo has launched the Sixer 180K, a flagship disposable vape built around a 6-in-1 architecture featuring six independent e-liquid tanks and six dedicated mesh coils. Alongside a claimed up to 180,000 puffs, the new device reflects a broader shift in disposable vape development from increasing puff counts toward modular hardware design and multi-flavor user experience.
Jul.03
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
Japan Tobacco International is stepping up its heated tobacco push in South Korea with Ploom AURA. Since its official launch in April 2026, the device's limited First Edition and Glacier White version have sold out, while distribution has expanded across Seoul, Incheon, Gyeonggi Province and airport duty-free channels. The rollout marks JTI's third major attempt to build a stronger heated tobacco position in South Korea, following Ploom TECH in 2019 and Ploom X Advanced in 2024. At the group level, JT plans to invest about ¥800 billion, approximately $5 billion, in reduced-risk products from 2026 through 2028, with heated products and Ploom identified as its primary investment priority.
Aug.14